CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM NEW
Total 13F shares
1,894,308
Share change
-204,075
Total reported value
$7,542,040
Price per share
$4.02
Number of holders
19
Value change
-$810,637
Number of buys
6
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q1 2015

As of 31 Mar 2015, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,894,308 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Stanley-Laman Group, Ltd., Longwood Capital Partners LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, Moors & Cabot, Inc., DAFNA Capital Management LLC, GRT CAPITAL PARTNERS LLC, GEODE CAPITAL MANAGEMENT, LLC, and ESSEX INVESTMENT MANAGEMENT CO LLC. This page lists 19 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.